More on ASCO 2020
At the end of May, myeloma researchers would have flocked to Chicago for the 56th Annual Meeting of the A...
Read moreResearch & Access Updates
Janssen Announces Health Canada Approval of DARZALEX®* SC, a New Subcutaneous Formulation for the Treatment of Patients with Multiple Myeloma
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that Health Canada has approved...
Read moreSeroprevalence Studies May Underestimate Immunity To The Coronavirus
Globally, there are more than 18 million confirmed novel coronavirus infections. A question many have is...
Read moreEmerging drugs for the treatment of light chain amyloidosis
Systemic AL amyloidosis is a protein-misfolding disorder that is characterized by the deposition of insol...
Read moreGood News: FDA Panel Votes to Approve Belantamab Mafodotin
On Tuesday, July 14, the U.S. Food & Drug Administration’s ODAC (the Oncologic Drugs Advisory Committee)...
Read moreEncouraging News Regarding Phase 3 BOSTON Study Announced
On May 28, 2020, Karyopharm presented positive data from their BOSTON study at the American Society of Cl...
Read more